Literature DB >> 3528496

A search for new group-B streptococcal serotypes.

J Motlová, M Wagner, J Jelínková.   

Abstract

New serotypes were sought among 165 clinical isolates of group-B streptococci that were untypable by antisera for the conventional types Ia, Ib, II and III. The strains were tested for sialic acid, an integral component of the group-B streptococcal type-polysaccharides; trypsin-treated bacteria were tested by slide-agglutination with the sialic-acid-specific lectin from the snail Cepaea hortensis. Sialic acid was detected in 96 of the strains; in 95 of these, new type antigens were identified serologically (type IV, 52; provisional type V, 34; candidate type NT6, seven; provisional type V and candidate type NT6, one; candidate type 7271, one); the remaining strain was found to possess a small amount of Ia antigen. Sialic acid was not detected in 69 strains, and none of these possessed a polysaccharide type-antigen. Chemical measurement of the sialic-acid content of cultures by Aminoff's method gave results in conformity with the lectin-agglutination test and the presence of polysaccharide type-antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3528496     DOI: 10.1099/00222615-22-2-101

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study.

Authors:  D W Denning; C J Baker; N J Troup; L S Tompkins
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

2.  Genetic diversity of rRNA operons of unrelated Streptococcus agalactiae strains isolated from cerebrospinal fluid of neonates suffering from meningitis.

Authors:  S Chatellier; H Huet; S Kenzi; A Rosenau; P Geslin; R Quentin
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

3.  Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis.

Authors:  L Tissi; P Marconi; P Mosci; L Merletti; P Cornacchione; E Rosati; S Recchia; C von Hunolstein; G Orefici
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

4.  Complement and antibody participation in opsonophagocytosis of type IV and V group B streptococci.

Authors:  M A Hall; M S Edwards; C J Baker
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

5.  Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease.

Authors:  R Quentin; H Huet; F S Wang; P Geslin; A Goudeau; R K Selander
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

6.  Screening of type Ia and Ib Streptococcus agalactiae strains with high sialic acid levels by determination of susceptibility to tetracyclines.

Authors:  Y Nagano; N Nagano; S Takahashi; A Suzuki; Y Okuwaki
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.